SAN DIEGO, March 2, 2016 /PRNewswire/ -- Today, DermTech, Inc., a privately held dermatology company commercializing non-invasive gene expression tests for skin cancer, announced a sales and marketing collaboration with Dermpath Diagnostics. Dermpath Diagnostics is a business...
